BridgeBio Oncology Therapeutics
BBOT
#9337
Rank
S$0.18 B
Marketcap
S$2.33
Share price
-6.70%
Change (1 day)
N/A
Change (1 year)

Quarterly Reports (10-Q)

Latest form 10-Q quarterly reports for BridgeBio Oncology Therapeutics CIK: 0001869105

Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2026 Q3

10-Q Quarterly Report FY2026 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2026 Q2

10-Q Quarterly Report FY2026 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2026 Q1

10-Q Quarterly Report FY2026 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2025 Q3

10-Q Quarterly Report FY2025 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2025 Q2

10-Q Quarterly Report FY2025 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2025 Q1

10-Q Quarterly Report FY2025 Q1

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2024 Q3

10-Q Quarterly Report FY2024 Q3

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2024 Q2

10-Q Quarterly Report FY2024 Q2

Language: English

Quarterly Reports (10-Q)
Thumbnail BridgeBio Oncology Therapeutics 10-Q Quarterly Report FY2024 Q1

10-Q Quarterly Report FY2024 Q1

Language: English

Quarterly Reports (10-Q)